Form 6-K XTL BIOPHARMACEUTICALS For: Sep 01

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. PCVX
3. TSLA
4. CME
5. USO
6. AMD
7. EVTL
8. ATH
9. SPY
10. KLC

Go back to Form 6-K XTL BIOPHARMACEUTICALS For: Sep 01

XTL Biopharma (XTLB) Reports Breakeven Q2 Loss

September 1, 2015 9:20 AM EDT

XTL Biopharma (NASDAQ: XTLB) reported Q2 loss of $0.00, versus $0.00 reported last year.

Following XTL's registered direct offering in April, 2015, XTL had US$4.8 million in cash and cash equivalents as of June 30, 2015.

For earnings history and earnings-related data on XTL Biopharma (XTLB) click here.

... More